Vascular targeted therapies for fibrotic lung disease: start of a new era?

European Respiratory Journal 2026

View at publisher
Authors: Albina Tyker, Laura C. Price, S. Nathan, Martin Kolb
DOI: 10.1183/13993003.00285-2026
Cited by: 1
References: 55

Abstract

Shareable abstract The vasculature in lungs with pulmonary fibrosis shows signs of vasculopathy independent of hemodynamic PH-ILD. This viewpoint briefly summarizes the evidence that vasculopathy can drive fibrosis progression and that targeting it is highly promising

Fields of Study & Subjects

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary Hypertension Research and Treatments Neonatal Respiratory Health Research

Publication details

Journal / source
European Respiratory Journal
Publisher
European Respiratory Society (ERS)
Volume
68
Issue
1
Pages
2600285–2600285
Publication date
7 May 2026
Language
EN